Evidence map›Paper›PMID 34362115›Full record

ArticleJournal of clinical medicine2021

Risk Factors for Orbital Implant Extrusion after Evisceration.

Ju-Mi Kim, Jae-Yun Sung, Hyung-Bin Lim, Eun-Jung Choi, Sung-Bok Lee

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ju-Mi KimDepartment of Ophthalmology, Chungnam National University College of Medicine, Daejeon 35015, Korea.ORCID 0000-0002-7241-1250
Jae-Yun SungDepartment of Ophthalmology, Chungnam National University College of Medicine, Daejeon 35015, Korea.
Hyung-Bin LimDepartment of Ophthalmology, Chungnam National University College of Medicine, Daejeon 35015, Korea.
Eun-Jung ChoiDepartment of Ophthalmology, Chungnam National University College of Medicine, Daejeon 35015, Korea.
Sung-Bok LeeDepartment of Ophthalmology, Chungnam National University College of Medicine, Daejeon 35015, Korea.ORCID 0000-0002-9665-6463
Chungnam National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study analyzed risk factors for extrusion of orbital implants after evisceration by comparing patients with and without implant extrusion.

methodsWe retrospectively reviewed the medical records of patients who underwent evisceration with primary implant placement by a single surgeon from January 2005 to December 2019 at the Chungnam National University Hospital. Age, sex, underlying systemic diseases, axial length of the fellow eye, the cause of evisceration, endophthalmitis type, implant type and size, and preoperative computed tomography findings were evaluated. Logistic regression analysis was used to identify the risk factors for implant extrusion.

resultsOf the 140 eyes of 140 patients, extrusion occurred in five eyes (3.6%). Endophthalmitis (odds ratio (OR), 15.49; 95% confidence interval (CI), 1.70 to 2038.56;

conclusionsEvisceration with primary orbital implantation is a feasible option in endophthalmitis, but the risk of extrusion should be taken into consideration. When performing evisceration in a patient with orbital cellulitis, secondary implantation should be carried out only after any infection is controlled.

Indexed as

cellulitisendogenous endophthalmitisendophthalmitiseviscerationextrusionrisk factor

Identifiers

PMID34362115
PMCPMC8347078
OpenAlexW3170177660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.